Filtered By:
Specialty: OBGYN
Condition: Hypertension

This page shows you your search results in order of date.

Order by Relevance | Date

Total 92 results found since Jan 2013.

Pregnancy-Associated Stroke and Outcomes Related to Timing and Hypertensive Disorders
CONCLUSION: A nationally representative sample of hospitalizations in the United States indicates an increasing trend in the rate of postpartum stroke. Almost half of hospitalizations with pregnancy-associated stroke have concomitant hypertensive disorders. Risk of adverse outcomes, but not mortality, is elevated in patients with stroke occurring in the postpartum period and stroke associated with hypertensive disorders.PMID:37411017 | DOI:10.1097/AOG.0000000000005249
Source: Obstetrics and Gynecology - July 6, 2023 Category: OBGYN Authors: Ghamar Bitar Baha M Sibai Han-Yang Chen Natalie Neff Sean Blackwell Suneet P Chauhan Michal Fishel Bartal Source Type: research

Pregnancy-associated stroke and the recurrence of stroke and other complications in subsequent pregnancies: Population-based retrospective cohort study
CONCLUSIONS: Subsequent pregnancies of women with a history of PAS are more often complicated with hypertensive disorders of pregnancy and any diabetes during pregnancy. PAS recurrence risk is considerable.PMID:37088716 | DOI:10.1111/1471-0528.17503
Source: BJOG : An International Journal of Obstetrics and Gynaecology - April 23, 2023 Category: OBGYN Authors: Liisa Verho Minna Tikkanen Outi Äyräs Karoliina Aarnio Kirsi Rantanen Aino Korhonen Anna Richardt Hannele Laivuori Mika Gissler Petra Ij äs Source Type: research

Preventing Adverse Cardiovascular Outcomes in Pregnancy Complicated by Obesity
AbstractPurpose of ReviewObesity is a chronic disease that is becoming increasingly prevalent, and more individuals of reproductive age have obesity prior to becoming pregnant. Obesity in pregnancy is associated with short- and long-term adverse consequences for both the birthing person and their offspring which have been associated with increased long-term cardiovascular morbidity and mortality. The goal of this review is to discuss what is currently understood about the relationship between maternal obesity and adverse pregnancy outcomes (APOs), the association between APOs and future cardiovascular disease (CVD) risk, a...
Source: Current Obstetrics and Gynecology Reports - April 6, 2023 Category: OBGYN Source Type: research

Stroke in Pregnancy
This article will review current information about the epidemiology, risk factors, pathophysiology, management, and outcomes of conditions associated with maternal stroke.Recent FindingsPregnancy confers a substantially increased risk of stroke in women. The period of highest risk of stroke is the peripartum and 6-week post-partum period, coinciding with the highest risk for hypertensive disorders of pregnancy and peak gestational hypercoagulability. Physiological changes of pregnancy, including hypercoagulable states, venous stasis, and hemodynamic changes, are significant contributors to maternal stroke. However, hyperte...
Source: Current Obstetrics and Gynecology Reports - February 22, 2023 Category: OBGYN Source Type: research

Pregnancy associated stroke and hypertension: a national cohort evaluating temporal trends, risk factors, and mortality
Our aim was to evaluate the association between pregnancy associated stroke (PAS) and hypertensive disorder in the U.S.
Source: American Journal of Obstetrics and Gynecology - January 1, 2023 Category: OBGYN Authors: Ghamar Bitar, Baha M. Sibai, Han-Yang Chen, Sami Backley, Suneet P. Chauhan, Michal Fishel Bartal Tags: Poster Session II Source Type: research

Furosemide to lower antenatal severe hypertension (FLASH): a randomized placebo-controlled trial
In high cardiac output hypertension, reducing volume may be an effective strategy in lowering blood pressure (BP). We evaluated whether the addition of IV furosemide to first-line antihypertensive agents reduces systolic BP (SBP) for the management of acute-onset, severe (SBP ≥160 mmHg and/or diastolic BP (DBP) ≥110 mmHg) antenatal hypertension with wide (≥60 mmHg) pulse pressure (PP), a proxy for stroke volume.
Source: American Journal of Obstetrics and Gynecology - January 1, 2023 Category: OBGYN Authors: Melanie Maykin, Elizabeth Mercer, Kevin Saiki, Bliss Kaneshiro, Corrie Miller, Pai Jong Tsai Tags: Poster Session III Source Type: research

Hypertensive Crisis in Pregnancy
Severe hypertension in pregnancy is a medical emergency, defined as systolic blood pressure (BP) ≥ 160 mm Hg and/or diastolic BP ≥ 110 mm Hg taken 15 minutes to 4 or more hours apart. Outside pregnancy, acute severe hypertension (HTN) is defined as a BP greater than 180/110 to 120 reproducible on 2 occasions. The lower threshold for severe HTN in pregnancy reflects the increased risk for adverse outcomes, particularly maternal stroke and death, and may be a source of under-recognition and treatment delay, particularly in nonobstetrical health care settings. Once a severe hypertension episode is recognized, antihyper...
Source: Obstetrics and Gynecology Clinics - September 1, 2022 Category: OBGYN Authors: Cynthie K. Wautlet, Maria C. Hoffman Source Type: research

The Preeclampsia Foundation: the voice and views of the patient and her family
Preeclampsia is a disease exclusive to pregnancy and the immediate postpartum period, occurring in 4.6% of pregnancies worldwide. Preeclampsia and other gestational hypertensive disorders can affect any pregnant woman. The consequences of developing this disease can lead to severe maternal and neonatal morbidities and mortalities, including fetal growth restriction, placental abruption, preterm birth, stillbirth, and maternal death. When pregnant women recover, they are at higher risk of long-term complications such as hypertension, stroke, heart failure, renal disease, and Alzheimer disease.
Source: American Journal of Obstetrics and Gynecology - August 31, 2021 Category: OBGYN Authors: Eleni Z. Tsigas Tags: Expert Review Source Type: research

No effect of calcium and vitamin D intake on maternal blood pressure in a healthy pregnant population
Pregnancy causes physiological changes in blood pressure (BP). In patients without pre-existing hypertension, BP falls during the first half of pregnancy and rises from 34 weeks onwards [1]. Hypertensive disorders in pregnancy (HDP) complicate approximately 10% of pregnancies and are associated with adverse outcomes for both mother and foetus [2]. Women with a history of HDP are also at increased risk of developing hypertension in later life as well as ischaemic heart disease, stroke and renal disease [3].
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - July 6, 2021 Category: OBGYN Authors: Hannah Forde, Rachel K. Crowley, Malachi J. McKenna, Mark T. Kilbane, Marie Conway, Ciara M. McDonnell, Patrick J. Twomey, Fionnuala M. McAuliffe Tags: Full length article Source Type: research

Factors associated with appropriate treatment of acute-onset severe obstetrical hypertension
The American College of Obstetricians and Gynecologists recommends that pregnant patients receive expeditious treatment with first-line antihypertensive agents within 1 hour of confirmed severe hypertension to reduce the risk for maternal stroke. However, it is unknown how often this guideline is followed and what factors influence a patient ’s likelihood of receiving guideline-concordant care.
Source: American Journal of Obstetrics and Gynecology - May 19, 2021 Category: OBGYN Authors: Uma S. Deshmukh, Lisbet S. Lundsberg, Jennifer F. Culhane, Caitlin Partridge, Uma M. Reddy, Audrey A. Merriam, Moeun Son Tags: SMFM Papers Source Type: research

Factors Associated with Appropriate Treatment of Acute-Onset Severe Obstetric Hypertension
The American College of Obstetricians and Gynecologists (ACOG) recommends pregnant patients receive expeditious treatment with first-line antihypertensive agents within one hour of confirmed severe hypertension to reduce the risk of maternal stroke. However, it is unknown how often this guideline is followed and what factors influence a patient ’s likelihood of receiving guideline-concordant care.
Source: American Journal of Obstetrics and Gynecology - May 19, 2021 Category: OBGYN Authors: Uma S. DESHMUKH, Lisbet S. LUNDSBERG, Jennifer F. CULHANE, Caitlin PARTRIDGE, Uma M. REDDY, Audrey A. MERRIAM, Moeun SON Tags: Original Research: Obstetrics Source Type: research

Pharmacist ’s knowledge regarding the management of overactive bladder in elderly women
Anticholinergic drugs used to treat overactive bladder (OAB), have common side effects, including constipation, dry eyes and dry mouth. They can also cause central nervous system effects such as confusion and reduction in cognitive function [1]. Polypharmacy and an increase in blood brain barrier permeability increase these effects [2] which, are more likely in the elderly [3] as aging, as well as trauma, multiple sclerosis, hypertension, stroke and diabetes [4], leads to increased blood brain barrier permeability.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - January 16, 2021 Category: OBGYN Authors: George Araklitis, Angie Rantell, Georgina Baines, Richard Flint, Dudley Robinson, Linda Cardozo Tags: Full length article Source Type: research

Migraine and menopause - a narrative review
Discussion and conclusion: Many women are informed that their migraines will disappear postmenopause; there are some data to support this, but a specific time frame has not been evidenced. Stroke risk in women with migraine with aura is small in absolute terms, but important at the population level, because migraine is so prevalent. The risk becomes clinically important in the context of additional stroke risk factors, which increase with aging such as hypertension. Estrogen in combined hormonal contraception increases the risk of an ischemic stroke, however, the lower amount of estrogen in HT may not contribute to a m...
Source: Menopause - January 1, 2021 Category: OBGYN Tags: Review Articles Source Type: research

Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
AbstractBACKGROUNDPolycystic ovary syndrome (PCOS) is associated with cardiometabolic disease, but recent systematic reviews and meta-analyses of longitudinal studies that quantify these associations are lacking.OBJECTIVE AND RATIONALEIs PCOS a risk factor for cardiometabolic disease?SEARCH METHODSWe searched from inception to September 2019 in MEDLINE and EMBASE using controlled terms (e.g. MESH) and text words for PCOS and cardiometabolic outcomes, including cardiovascular disease (CVD), stroke, myocardial infarction, hypertension (HT), type 2 diabetes (T2D), metabolic syndrome and dyslipidaemia. Cohort studies and case ...
Source: Human Reproduction Update - September 30, 2020 Category: OBGYN Source Type: research